147 related articles for article (PubMed ID: 15233659)
21. The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer.
Chen TS; Chang FY; Ng WW; Lee FY; Hwang SJ; Lee SD
Hepatogastroenterology; 1999; 46(28):2372-8. PubMed ID: 10522000
[TBL] [Abstract][Full Text] [Related]
22. Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test.
Shirin H; Frenkel D; Shevah O; Levine A; Bruck R; Moss SF; Niv Y; Avni Y
Am J Gastroenterol; 2003 Jan; 98(1):46-50. PubMed ID: 12526935
[TBL] [Abstract][Full Text] [Related]
23. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
Levine A; Shevah O; Shabat-Sehayek V; Aeed H; Boaz M; Moss SF; Niv Y; Avni Y; Shirin H
Aliment Pharmacol Ther; 2004 Jul; 20(1):117-22. PubMed ID: 15225178
[TBL] [Abstract][Full Text] [Related]
24. An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease.
Yap LM; Hagan S; Craig A; Hebbard GG; Young GP; Bampton PA
Endoscopy; 2004 Apr; 36(4):371-2; author reply 372-3. PubMed ID: 15057696
[No Abstract] [Full Text] [Related]
25. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
Wurzer H; Schutze K; Bethke T; Fischer R; Luhmann R; Riesenhuber C
Hepatogastroenterology; 1999; 46(27):1809-15. PubMed ID: 10430350
[TBL] [Abstract][Full Text] [Related]
26. [Are proton pump inhibitors safe?].
Creutzfeldt W
Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
[No Abstract] [Full Text] [Related]
27. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
28. Dosage of intravenous pantoprazole.
Maltz C
Am J Gastroenterol; 2003 Dec; 98(12):2803-5. PubMed ID: 14687838
[No Abstract] [Full Text] [Related]
29. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
30. Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.
McGowan B; Bennett K; Tilson L; Barry M
Ir Med J; 2005 Mar; 98(3):78-80. PubMed ID: 15869064
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitors and acute interstitial nephritis.
Geevasinga N; Coleman PL; Webster AC; Roger SD
Clin Gastroenterol Hepatol; 2006 May; 4(5):597-604. PubMed ID: 16630752
[TBL] [Abstract][Full Text] [Related]
32. Switching between intravenous and oral pantoprazole.
Pisegna JR
J Clin Gastroenterol; 2001 Jan; 32(1):27-32. PubMed ID: 11154164
[TBL] [Abstract][Full Text] [Related]
33. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
34. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
[TBL] [Abstract][Full Text] [Related]
35. The proton-pump inhibitors: similarities and differences.
Horn J
Clin Ther; 2000 Mar; 22(3):266-80; discussion 265. PubMed ID: 10963283
[TBL] [Abstract][Full Text] [Related]
36. Long-term prescribing of proton pump inhibitors in general practice.
Hungin AP; Rubin GP; O'Flanagan H
Br J Gen Pract; 1999 Jun; 49(443):451-3. PubMed ID: 10562744
[TBL] [Abstract][Full Text] [Related]
37. Intravenous proton pump inhibition utilization and prescribing patterns escalation: a comparison between early and current trends in use.
Law JK; Andrews CN; Enns R
Gastrointest Endosc; 2009 Jan; 69(1):3-9. PubMed ID: 18718583
[TBL] [Abstract][Full Text] [Related]
38. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Ramdani A; Mignon M; Samoyeau R
Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
[TBL] [Abstract][Full Text] [Related]
39. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
Becker TL; Maróstica M; Ribeiro ML; de Mendonça S; Gambero A; Pedrazzoli J
Int Immunopharmacol; 2004 Aug; 4(8):1051-7. PubMed ID: 15222979
[TBL] [Abstract][Full Text] [Related]
40. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]